15
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Potent and selective cyclooxygenase-2 inhibitors from three structural classes

Pages 101-103 | Published online: 25 Feb 2005
 

Abstract

These patents cover three different ‘classes’ of agents reported to be selective cyclooxygenase-2 (COX-2) inhibitors. Derivitisation of the carboxyl moiety of the known non-selective acidic non-steroidal anti-inflammatory drug (NSAID) sulindac is exemplified by the WO9821195 patent (American Home Products). Another patent in the growing classes of sulfonyl-substituted diarylheterocycles area is WO9805639 (Laboratoires UPSA). A substantially new pharmacophore motif derived from research on the meloxicam series is exemplified by US5741798 (Boehringer Ingelheim Pharm.). Of these patents, only the Boehringer Ingelheim patent provides biological data supporting in vivo utility of this class.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.